Think global, act local - Romaco's approach to the Indian pharma market

The Indian pharmaceutical market is dynamic and increasingly international, which is reflected in trade fairs such as CPHI & PMEC India. Jens Torkel, MD, Romaco Group, a leading international supplier of machines and integrated system solutions for the development, manufacture and packaging of pharmaceuticals, and Sanjeev A. Nimkar, MD, Romaco India, Romaco's Sales & Service Centre based in Mumbai, underline the importance of the CPHI & PMEC and explain how machine manufacturers are meeting the requirements of pharma companies in India

What industry trends are you noticing at CPHI & PMEC this year, and how is your company positioned to address them?

Torkel: Two of the major trends are increased digitalisation and more sustainability initiatives, particularly, but not exclusively, with regard to reducing emissions and saving energy.

Romaco is very well positioned for this development because we have been putting sustainability at the heart of our machine design, production and business processes in general for quite some time. As a result of this early implementation, our machines are ready to help the pharmaceutical industry to produce more sustainably for example, by reducing energy and material consumption, shortening process times and lowering CO2 emissions. For our commitment, we recently received a gold medal in the EcoVadis Sustainability Ranking, putting us in the top two per cent of rated companies.

Nimkar: What this trend towards sustainability also implies, is the need for more effective and efficient production, which is a major topic for Indian contract manufacturers, for example. The beauty of it is that sustainability, effectiveness and efficiency go hand in hand in pharma production when solutions address aspects such as process times or resource consumption.

One of our latest innovations in this area are energy recovery systems for drum coaters and fluid bed processers, that allow to cut the consumption of heat energy by up to 50 per cent in tablet coating and up to 70 per cent with fluid bed processors, depending on the product and the process.

How has CPHI & PMEC helped shape your company's strategy or product offerings in recent years?